Skip to main content

CalciMedica, Inc.

CALC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001534133

No open-market purchases or sales by CalciMedica, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $8.39M in total; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding CalciMedica, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of CALC: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders5141−10
Shares13.1M11.7M−1.37M (−10.5%)
Value$72.8M$63.7M−$9.04M (−12.4%)

New holders (17)

Institutions that held CalciMedica, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to CALC in Q2 2021
InstitutionSharesValue% of portfolio
First Manhattan Co292,003$1.58M0.01%
Susquehanna International Group, LLP268,783$1.46M0.00%
Sculptor Capital LP130,900$711.0K0.01%
HRT Financial LP28,220$153.0K0.00%
Millennium Management LLC23,165$126.0K0.00%
Two Sigma Securities, LLC20,345$110.0K0.03%
Ergoteles LLC17,700$96.0K0.00%
Squarepoint Ops LLC17,580$95.0K0.00%
Group One Trading, L.P.15,870$86.0K0.00%
Ameriprise Financial Inc12,305$67.0K0.00%
Simplex Trading, LLC8,176$44.0K0.00%
Cutler Group LP5,200$28.0K0.00%
Advisor Group Holdings, Inc.4,250$22.0K0.00%
Point72 Hong Kong Ltd3,500$19.0K0.00%
Spire Wealth Management1,200$7.00K0.00%
Newbridge Financial Services Group, Inc.1,000$5.00K0.00%
Advisory Services Network, LLC631$3.00K0.00%

Sold out (27)

Institutions that held CalciMedica, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.